Boehringer Ingelheim: all 2,305 studies
Page 5 of 24. Open to participants first (62), then studies with results posted, then the rest; newest registration first within each.
- Testing Afatinib in Combination With Pembrolizumab in Patients With Squamous Cell Carcinoma of the LungCompletedNCT03157089Phase 2Results posted
- This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment.CompletedNCT03156114Phase 1Results posted
- Drug-drug Interaction Trial Between Rifampicin and BI 409306 in Healthy VolunteersCompletedNCT03151499Phase 1Results posted
- Pradaxa Tablet Proton Pump Inhibitor (PPI) Bioavailability (BA) Study in JapanCompletedNCT03143166Phase 1Results posted
- BI 443651 Methacholine ChallengeCompletedNCT03135899Phase 1Results posted
- Initial Dosing of BI 655130 in Palmoplantar Pustulosis PatientsCompletedNCT03135548Phase 2Results posted
- Health-related Quality of Life in Patients on AnticoagulantsCompletedNCT03134911Results posted
- Safety and Pharmacokinetics of Single Rising Doses of BI 705564 and Food Effect on BI 705564 in Healthy Male SubjectsCompletedNCT03123185Phase 1Results posted
- A Study in Patients With Mild or Moderate Ulcerative Colitis Who Take a TNF Inhibitor. The Study Investigates Whether Bowel Inflammation Improves When Patients Take BI 655130 in Addition to Their Current TherapyCompletedNCT03123120Phase 2Results posted
- Single Rising Dose Trial of Spesolimab (BI 655130) for Healthy Japanese Male SubjectsCompletedNCT03123094Phase 1Results posted
- Safety, Tolerability, and Pharmacokinetics of a Subcutaneous and Intravenous Dose of BI 655130 in Healthy SubjectsCompletedNCT03100903Phase 1Results posted
- This Study Tests How BI 655130 Works in Patients With Active Ulcerative Colitis. The Study Also Tests How Well BI 655130 is Tolerated and Whether it Helps the PatientsCompletedNCT03100864Phase 2Results posted
- This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast CancerCompletedNCT03099174Phase 1Results posted
- Clinical Characteristics and Practice Patterns of Type 2 Diabetes Mellitus Patients Treated With OADs in Japan: Analysis of Medical and Health Care Database of the MDVCompletedNCT03092752Results posted
- Study to Investigate the Pharmacokinetics (PK) and Pharmacodynamics (PD) of Idarucizumab in Chinese Healthy Male and Female Volunteers Who Had Taken Dabigatran Etexilate and Whose Plasma Concentrations of Dabigatran Were at or Close to Steady StateCompletedNCT03086356Phase 1Results posted
- A Study in Healthy Men to Test Whether Rifampicin Influences the Amount of BI 425809 in the BloodCompletedNCT03082183Phase 1Results posted
- Real World Data on Management of Male LUTSCompletedNCT03075449Results posted
- Comparison of the Bioavailability of Diclofenac in a Combination Product (Diclofenac 2% + Capsaicin 0.075% Topical Gel) With Two Diclofenac Only Products, Diclofenac Mono Gel 2% and Voltarol® 12 Hour Emulgel 2.32% Gel, in Healthy VolunteersCompletedNCT03074162Phase 1Results posted
- Investigating Idiopathic Pulmonary Fibrosis in GreeceCompletedNCT03074149Results posted
- Bioequivalence of Tablet Formulation of Dabigatran Etexilate Compared to Commercial Capsule Formulation Following Oral Administration in Healthy Male SubjectsCompletedNCT03070171Phase 1Results posted
- Clinical Characteristics, Anti-hyperglycaemic Treatment Pattern and Target Attainment of Type 2 Diabetes Mellitus Patients in Older Population With or Without Albuminuria in ChinaCompletedNCT03064841Results posted
- EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)CompletedNCT03057977Phase 3Results posted
- EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)CompletedNCT03057951Phase 3Results posted
- Cardiovascular Function in COPD PatientsCompletedNCT03055988Phase 4Results posted
- Characteristics of Empagliflozin InitiatorsCompletedNCT03050619Results posted
- Post Marketing Surveillance of Nintedanib in Indian Patients With Idiopathic Pulmonary FibrosisCompletedNCT03047031Results posted
- Drug Utilization Study for OlodaterolCompletedNCT03030638Results posted
- The Comparative Safety and Effectiveness of Dabigatran, Versus Rivaroxaban, and Apixaban Utilized in the Department of Defense Non-Valvular Atrial Fibrillation Patient Population: A Retrospective Database AnalysisCompletedNCT03026556Results posted
- To Evaluate Real-world Safety, Effectiveness and Appropriate Use of Micatrio® Combination Tablets Treatment in Patients With HypertensionCompletedNCT03021265Results posted
- Post Marketing Surveillance of Nintedanib in Indian Patients With Non-small Cell Lung Cancer (NSCLC) After First-line TherapyCompletedNCT03017885Results posted
- Validation of Predictors of OAC Initiation Using EMR DataCompletedNCT03006341Results posted
- To Assess Safety, Tolerability and Pharmacokinetics of BI 730357 in Healthy Male VolunteersCompletedNCT03004404Phase 1Results posted
- Effectiveness and Handling of Spiolto® Respimat ® in COPD Patients - ItalyCompletedNCT03003494Results posted
- Ibuprofen/Caffeine Lower Back or Neck Pain StudyCompletedNCT03003000Phase 3Results posted
- Relative Bioavailability of BI 1467335 Tablet and Oral Solution, and Food Effect on Tablet in Healthy Male SubjectsCompletedNCT02999191Phase 1Results posted
- Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)CompletedNCT02999178Phase 3Results posted
- Treatment Pattern of Oral Anticoagulants (OAC) in JapanCompletedNCT02982863Results posted
- Spesolimab (BI 655130) Single Dose in Generalized Pustular PsoriasisCompletedNCT02978690Phase 1Results posted
- BI 443651 Multiple Rising Dose in Healthy Volunteers Followed by a Cross-over in CF SubjectsCompletedNCT02976519Phase 1Results posted
- Bioavailability of Tiotropium + Olodaterol Fixed-dose Combination (5 μg/ 5 μg) in Chinese COPD PatientsCompletedNCT02969317Phase 1Results posted
- Bioequivalence of a Fixed Dose Combination Tablet Containing 400 mg Ibuprofen and 60 mg Pseudoephedrine-HCl Compared to Two Film Coated Fixed Dose Combination Tablets RhinAdvil(R)(200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl) Administered in Healthy SubjectsCompletedNCT02963701Phase 1Results posted
- A Trial to Find and Investigate a Safe Dose of a New Substance (BI 754091) for Patients With Solid TumoursCompletedNCT02952248Phase 1Results posted
- All-Case Surveillance of Prizbind®CompletedNCT02946931Results posted
- Safety and Efficacy of Alteplase When Administered in Chinese Patients With Acute Ischemic Hemispheric Stroke Where Thrombolysis is Initiated Between 3 and 4.5 Hours After Stroke OnsetCompletedNCT02930837Phase 3Results posted
- OTIVACTO Spain Non Interventional StudyCompletedNCT02927795Results posted
- A Clinical Trial Comparing Efficacy and Safety of Dabigatran Etexilate With Warfarin in Patients With Cerebral Venous and Dural Sinus Thrombosis (RE-SPECT CVT)CompletedNCT02913326Phase 3Results posted
- Observational Prospective Study to Evaluate AEs, Risk Factors and Drug Utilization of BUSCAPINA COMPOSITUM N in Adults From Metropolitan LimaCompletedNCT02910167Results posted
- Pharmacokinetics and Safety of BI 695501CompletedNCT02899338Phase 1Results posted
- Linagliptin Add-on to Insulin Background TherapyCompletedNCT02897349Phase 3Results posted
- BI 695501 Versus Humira in Patients With Active Crohn's Disease: a Trial Comparing Efficacy, Endoscopic Improvement, Safety, and ImmunogenicityCompletedNCT02871635Phase 3Results posted
- Post-authorisation Safety Study in Patients With Type 2 Diabetes to Assess the Risk of Liver Injury, Kidney Injury, Urinary Tract and Genital Infections, and Diabetic Ketoacidosis in Patients Treated With Empagliflozin, Compared to DPP-4 InhibitorsCompletedNCT02864914Results posted
- Vahelva Respimat Regulatory Post-marketing Surveillance in Korean Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT02864407Results posted
- Transporter Cocktail Mutual InteractionCompletedNCT02854527Phase 1Results posted
- Influence of Fluvoxamine on the Pharmacokinetics of BI 409306CompletedNCT02853136Phase 1Results posted
- Effect of Tiotropium + Olodaterol on Breathlessness in COPD PatientsCompletedNCT02853123Phase 4Results posted
- Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 655130 in Healthy Male VolunteersCompletedNCT02852824Phase 1Results posted
- Long-term Use of Spiolto Respimat in Japanese Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT02850978Results posted
- Efficacy, Safety and Immunogenicity of BI 695501 Versus Humira® in Patients With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT02850965Phase 3Results posted
- Patient Convenience Study- NIS RELATECompletedNCT02849509Results posted
- JARDIANCE Regulartory Post Marketing Surveillance in Korean Type 2 Diabetes MellitusCompletedNCT02848833Results posted
- Treatment Convenience in Patients Treated With Dabigatran for Stroke Prophylaxis in Atrial Fibrillation (SPAF)CompletedNCT02839746Results posted
- Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in SchizophreniaCompletedNCT02832037Phase 2Results posted
- CU Programme of Idarucizumab for Japanese PatientsCompletedNCT02831660Phase 3Results posted
- Japanese IP-TN TrialCompletedNCT02831569Phase 3Results posted
- Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Linagliptin/Metformin Extended Release Compared With Single TabletsCompletedNCT02821910Phase 1Results posted
- Reversal Dabigatran Anticoagulant Effect With IdarucizumabCompletedNCT02815670Phase 3Results posted
- Empa/Lina FDC Food Effect Study (Japan)CompletedNCT02815644Phase 1Results posted
- IPF Italian Observational Study (FIBRONET) in Idiopathic Pulmonary FibrosisCompletedNCT02803580Results posted
- Efficacy and Safety of Nintedanib Co-administered With Sildenafil in Idiopathic Pulmonary Fibrosis Patients With Advanced Lung Function ImpairmentCompletedNCT02802345Phase 3Results posted
- BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease.CompletedNCT02788513Phase 2Results posted
- Effect of Nintedanib on Biomarkers of Extracellular Matrix Turnover in Patients With Idiopathic Pulmonary Fibrosis and Limited Forced Vital Capacity ImpairmentCompletedNCT02788474Phase 4Results posted
- Anticoagulants Comparative Benefit-risk Ratio in Real LifeCompletedNCT02785354Results posted
- Interaction of BI 425809 With Midazolam, Warfarin, Omeprazole and DigoxinCompletedNCT02783040Phase 1Results posted
- Nintedanib Alone or in Combination With Capecitabine in Refractory Metastatic Colorectal Cancer [LUME-Colon 2]TerminatedNCT02780700Phase 2Results posted
- Afatinib Monotherapy in Patients With ERBB-deregulated Metastatic Urothelial Tract Carcinoma After Failure of Platinum Based ChemotherapyCompletedNCT02780687Phase 2Results posted
- Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal CancerCompletedNCT02776683Phase 3Results posted
- Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus NephritisCompletedNCT02770170Phase 2Results posted
- Intravenous BI 836826 in Combination With Ibrutinib in Relapsed/Refractory CLL Patients Who Have Been Pre-treated With at Least One Prior Line of Systemic Therapy, and Who Are Eligible for Treatment With IbrutinibCompletedNCT02759016Phase 1Results posted
- Bioequivalence of a Fixed Dose Combination Tablet of Empagliflozin/Linagliptin Compared With the Free Combination of Empagliflozin Tablet and Linagliptin Tablet in Healthy Male and Female SubjectsCompletedNCT02758171Phase 1Results posted
- Real World Data on Gi(l)Otrif® Dose AdjustmentCompletedNCT02751879Results posted
- Investigation of the Effect of Nintedanib on the Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Patients With Non-small Cell Lung CancerTerminatedNCT02751385Phase 1Results posted
- To Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1467335 Following Multiple Dose Administration Over 28 DaysCompletedNCT02733627Phase 1Results posted
- Safety and Effect on Central Retinal Thickness of BI 1026706 in Patients With Diabetic Macular EdemaCompletedNCT02732951Phase 2Results posted
- Trial of Volasertib With or Without Azacitidine in Patients With Myelodysplastic SyndromesTerminatedNCT02721875Phase 1Results posted
- Assessment of Physical Functioning and Handling of Spiolto Respimat in Patients With COPD (OTIVACTO)TerminatedNCT02720757Results posted
- OTIVACTO Regional Center Vienna (RCV) Non-Interventional Study (NIS)CompletedNCT02719639Results posted
- Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease)CompletedNCT02719184Results posted
- Bioavailability Study of Five Tablet Formulations of Dabigatran Etexilate Compared to Commercial Capsule Formulation in Healthy Male SubjectsCompletedNCT02710630Phase 1Results posted
- To Assess Safety, Tolerability and Pharmacokinetics of BI 443651 in Healthy Male VolunteersCompletedNCT02706925Phase 1Results posted
- Empa Add on to Insulin in Japanese Patient With Type 1 Diabetes MellitusCompletedNCT02702011Phase 2Results posted
- Capsaicin + Diclofenac Gel in Acute Back Pain or Neck PainCompletedNCT02700815Phase 3Results posted
- Single Rising Dose Study of BI 655088 Administered Intravenously in Healthy Male VolunteersCompletedNCT02696616Phase 1Results posted
- Afatinib in EGFR+NSCLC (Recurrent or Stage IV) - Patients With Poor Performance Status (ECOG 2 or 3)TerminatedNCT02695290Phase 4Results posted
- Weekly BI 836880 in Patients With Advanced Solid TumorsCompletedNCT02689505Phase 1Results posted
- SATisfaction and Adherence to COPD TreatmentCompletedNCT02689492Results posted
- Patient Convenience Study (RE-SONANCE)CompletedNCT02684981Results posted
- Fixed Dose Combination Versus Free Combination of Tiotropium and Olodaterol in COPDCompletedNCT02683109Phase 4Results posted
- Assessment of Physical Functioning and Handling of Spiolto® Respimat® in Patients With Chronic Obstructive Pulmonary Disease (COPD) Requiring Long-acting Dual Bronchodilation in Routine Clinical PracticeCompletedNCT02675517Results posted
- Dose Finding Study of BI 836880 in Patients With Solid TumorsCompletedNCT02674152Phase 1Results posted
- LUME BioNIS: a Biomarker Study in Patients With NSCLCCompletedNCT02671422Results posted